Aduro Biotech (ADRO) Reports Q1 Loss of $0.45

Aduro Biotech (NASDAQ: ADRO) reported Q1 EPS of ($0.45), versus ($39.97) reported last year.

For earnings history and earnings-related data on Aduro Biotech (ADRO) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Eltek Ltd (ELTK) Reports Q2 EPS of $0.41
• GLJ Research on Sell Rated Tesla (TSLA): 'We now see FSD as the main reason TSLA’s stock will bleed lower this year'